secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75328 grounded facts newest July 10, 2026, 5:10 PM ET RSS · JSON

Showing 3451–3500 of 18397

Departed (interim)

Mario Longhi

Interim President and Chief Executive Officer
UGI · UGI CORP /PA/
Effective
2024-11-01
Successor
Robert Flexon
Filed
October 15, 2024, 7:59 PM ET
Mario Longhi will cease serving as Interim President and Chief Executive Officer, effective November 1, 2024.
Appointed

Robert Flexon

President and Chief Executive Officer
UGI · UGI CORP /PA/
Effective
2024-11-01
Successor
Mario Longhi
Filed
October 15, 2024, 7:59 PM ET
appointed Robert Flexon as President and Chief Executive Officer, effective November 1, 2024.
Appointed

Keith Walsh

Executive Vice President and Chief Financial Officer
AIG · AMERICAN INTERNATIONAL GROUP, INC.
Effective
2024-11-06
Filed
October 11, 2024, 7:59 PM ET
reporting the appointment of Keith Walsh as Executive Vice President and Chief Financial Officer.
Departed

Sabra Purtill

Executive Vice President and Chief Financial Officer
AIG · AMERICAN INTERNATIONAL GROUP, INC.
Effective
2024-11-06
Successor
Keith Walsh
Filed
October 11, 2024, 7:59 PM ET
Sabra Purtill will continue to serve as Executive Vice President and Chief Financial Officer until such date.
Appointed

Kyle Gano

President and Chief Executive Officer
NBIX · NEUROCRINE BIOSCIENCES INC
Effective
2024-10-11
Filed
October 11, 2024, 7:59 PM ET
Pursuant to the Employment Agreement, Dr. Gano will serve as Neurocrine Biosciences’ President and Chief Executive Officer effective October 11, 2024 (the “Effective Date”).
Departed

Christopher Savoie

President and Chief Executive Officer
ZPTA · Zapata Quantum, Inc.
Effective
2024-10-07
Successor
Sumit Kapur
Filed
October 11, 2024, 7:59 PM ET
On October 7, 2024, Christopher Savoie resigned as President and Chief Executive Officer of the Company, as well as a member of the board of directors of the Company, in each case effective immediately.
Appointed

Sumit Kapur

Chief Executive Officer
ZPTA · Zapata Quantum, Inc.
Effective
2024-10-07
Filed
October 11, 2024, 7:59 PM ET
The board of directors of the Company has appointed Sumit Kapur, the Company’s Chief Financial Officer, to serve as the Chief Executive Officer and principal executive officer, effective immediately.
Appointed

Sherri R. Luther

Chief Financial Officer and Treasurer
COHR · COHERENT CORP.
Effective
2024-10-11
Filed
October 11, 2024, 7:59 PM ET
appointed Sherri R. Luther as the Company’s Chief Financial Officer (“CFO”) and Treasurer, effective October 11, 2024
Role change

Richard J. Martucci

Interim Chief Financial Officer
COHR · COHERENT CORP.
Effective
2024-10-11
Successor
Sherri R. Luther
Filed
October 11, 2024, 7:59 PM ET
Mr. Martucci will remain with the Company in a non-executive officer role.
Appointed

Xiaoyue Zhang

Chief Financial Officer
Wave Sync Corp.
Effective
2024-10-07
Filed
October 11, 2024, 7:59 PM ET
The Board also approved the appointment of Xiaoyue Zhang, a current member of the Board, as Chief Financial Officer (the “CFO”) of the Company, effective as of October 7, 2024.
Appointed

Hong Chen

Chief Executive Officer and Chairman of the Board
Wave Sync Corp.
Effective
2024-10-07
Filed
October 11, 2024, 7:59 PM ET
On October 7, 2024, the Board of Directors (the “Board”) approved the appointment of Hong Chen, a current member of the Board, as Chief Executive Officer (the “CEO”) and Chairman of the Board of the Company, effective as of October 7, 2024.
Departed

Hon Man Yun

Chief Executive Officer
Wave Sync Corp.
Effective
2023-10-03
Successor
Hong Chen
Filed
October 11, 2024, 7:59 PM ET
On October 3, 2023, Hon Man Yun passed away, thereby concluding his position as Chief Executive Officer of Wave Sync Corp.
Appointed (interim)

Rakesh Prasad

Interim Chief Financial Officer (and principal financial and accounting officer)
AIRE · reAlpha Tech Corp.
Effective
2024-10-10
Filed
October 11, 2024, 7:59 PM ET
On the same date, the Company appointed Rakesh Prasad, the Company’s Vice President of Finance, to serve as its Interim Chief Financial Officer (and principal financial and accounting officer), effective immediately, while the Company conducts its search for a new Chief Financial Officer.
Departed

William B. Miller

Chief Financial Officer (and principal financial and accounting officer)
AIRE · reAlpha Tech Corp.
Effective
2024-10-10
Successor
Rakesh Prasad
Filed
October 11, 2024, 7:59 PM ET
On October 10, 2024, William B. Miller resigned from his position as Chief Financial Officer (and principal financial and accounting officer) of reAlpha Tech Corp. (the “Company”) and its subsidiaries, effective immediately.
Appointed (interim)

Tonya Stevens

Interim Chief Financial Officer
LSCC · LATTICE SEMICONDUCTOR CORP
Effective
2024-10-10
Filed
October 11, 2024, 7:59 PM ET
On October 11, 2024, Lattice Semiconductor Corporation (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Tonya Stevens, the Company’s current Corporate Vice President and Corporate Controller, as Interim Chief Financial Officer in addition to her existing position at the Company, effective October 10, 2024.
Departed

Sherri Luther

Chief Financial Officer
LSCC · LATTICE SEMICONDUCTOR CORP
Effective
2024-10-10
Successor
Tonya Stevens
Filed
October 11, 2024, 7:59 PM ET
The appointment follows the resignation of Sherri Luther on October 10, 2024, from her position as Chief Financial Officer, effective immediately.
Appointed (interim)

Jonathan Javitt

Interim Chief Executive Officer
NRXP · NRX Pharmaceuticals, Inc.
Effective
2024-10-07
Filed
October 11, 2024, 7:59 PM ET
Jonathan Javitt, Chairman of the Board of Directors of the Company, was appointed as Interim Chief Executive Officer concurrent with Mr. Willard’s resignation.
Departed

Stephen Willard

Chief Executive Officer
NRXP · NRX Pharmaceuticals, Inc.
Effective
2024-10-07
Successor
Jonathan Javitt
Filed
October 11, 2024, 7:59 PM ET
On October 7, 2024, Stephen Willard, the Chief Executive Officer of NRx Pharmaceuticals, Inc. (the “ Company ”) provided notice to the Board that he was resigning from the Company, effective immediately
Appointed (interim)

Mark Lynch

Interim Chief Financial Officer
APPN · APPIAN CORP
Effective
2024-11-04
Filed
October 11, 2024, 7:59 PM ET
Mark Lynch, a member of the Company’s Board of Directors, will serve as Interim Chief Financial Officer ("Interim CFO") effective as of November 4, 2024
Departed

Mark Matheos

Chief Financial Officer
APPN · APPIAN CORP
Effective
2024-11-08
Filed
October 11, 2024, 7:59 PM ET
Mark Matheos, Chief Financial Officer of Appian Corporation (the “Company”) notified the Company that he will be leaving the Company effective November 8, 2024, to pursue an opportunity as a CFO at another company.
Appointed

Taylor E. Luebke

Senior Vice President and Chief Financial Officer
LZB · LA-Z-BOY INC
Effective
2025-01-01
Filed
October 10, 2024, 7:59 PM ET
the Board of Directors of the Company elected Taylor E. Luebke to succeed Mr. Lucian as Senior Vice President and Chief Financial Officer of the Company, effective January 1, 2025.
Departed

Robert G. Lucian

Senior Vice President and Chief Financial Officer
LZB · LA-Z-BOY INC
Effective
2025-04-26
Successor
Taylor E. Luebke
Filed
October 10, 2024, 7:59 PM ET
Robert G. Lucian, Senior Vice President and Chief Financial Officer, informed La-Z-Boy Incorporated (the “Company”) of his planned retirement from the Company at the end of the fiscal year, effective April 26, 2025.
Departed

Stephen Kok Koon Tan

Chief Executive Officer
SNTW · Summit Networks Inc.
Effective
2024-10-07
Filed
October 10, 2024, 7:59 PM ET
On October 7, 2024, Mr. Stephen Kok Koon Tan resigned as CEO and director of Summit Networks Inc. (the “Company”).
Role change (interim)

Barry Shin

Executive Vice President, Chief Operating Officer and Chief Financial Officer
TREVENA INC
Effective
2024-10-05
Filed
October 10, 2024, 7:59 PM ET
approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer
Role change (interim)

Carrie L. Bourdow

President and Chief Executive Officer
TREVENA INC
Effective
2024-10-05
Filed
October 10, 2024, 7:59 PM ET
approved the termination of employment, without cause, of Carrie L. Bourdow, the Company’s President and Chief Executive Officer; Barry Shin, the Company’s Executive Vice President, Chief Operating Officer and Chief Financial Officer; and Mark A. Demitrack, MD, the Company’s Senior Vice President and Chief Medical Officer
Departed

Wynne Comer

interim Chief Financial Officer
AGL Private Credit Income Fund
Effective
2024-10-08
Successor
Ted Gilpin
Filed
October 10, 2024, 7:59 PM ET
On October 8, 2024, Wynne Comer resigned from her position as the interim Chief Financial Officer of AGL Private Credit Income Fund (the “Company”), effective on such date.
Appointed

Ted Gilpin

Chief Financial Officer
AGL Private Credit Income Fund
Effective
2024-10-08
Filed
October 10, 2024, 7:59 PM ET
On October 8, 2024, the Board of Trustees (the “Board”) of Company appointed Ted Gilpin to serve as the Company’s Chief Financial Officer, effective on October 8, 2024.
Appointed (interim)

Warren F. Kruger

Chief Financial Officer
GLGI · GREYSTONE LOGISTICS, INC.
Effective
2024-10-09
Filed
October 10, 2024, 7:59 PM ET
Mr. Warren F. Kruger, Greystone's CEO, President, Chairman of the Board and a significant stockholder of Greystone, will assume the position of Chief Financial Officer (principal financial officer and principal accounting officer) until such time as a permanent candidate is employed.
Departed

R. Brice Dille

Interim Chief Financial Officer
GLGI · GREYSTONE LOGISTICS, INC.
Effective
2024-10-09
Successor
Warren F. Kruger
Filed
October 10, 2024, 7:59 PM ET
Mr. R. Brice Dille has been relieved of his position as Interim Chief Financial Officer (principal financial officer and principal accounting officer) effective October 9, 2024.
Appointed

J. Michael Edwards

Chief Financial Officer
BIAF · bioAffinity Technologies, Inc.
Effective
2024-11-05
Filed
October 10, 2024, 7:59 PM ET
On October 4, 2024, the Board of Directors (the “Board”) of bioAffinity technologies, Inc. (the “Company”) appointed J. Michael Edwards, who has served as the Company’s Interim Chief Financial Officer, as a consultant, since September 2024, to serve as Chief Financial Officer of the Company, effective November 5, 2024.
Appointed

Neil Warma

President and Chief Executive Officer
PMN · ProMIS Neurosciences Inc.
Effective
2024-08-01
Filed
October 10, 2024, 7:59 PM ET
On October 8, 2024, ProMIS Neurosciences Inc. (the “Company”) appointed Neil Warma as the President and Chief Executive Officer (“CEO”) of the Company, effective August 1, 2024.
Departed

Alexander Valdes

Chief Financial Officer
IDAI · T Stamp Inc
Effective
2025-01-02
Filed
October 10, 2024, 7:59 PM ET
On October 4, 2024, Alexander Valdes, the Chief Financial Officer of T Stamp Inc., a Delaware corporation (the “Company”), submitted a notice of non-renewal of his employment agreement with the Company, providing a 90-day notice in accordance with the terms of his employment agreement, which was accepted by the Company.
Appointed

Brendan Shanahan

Chief Financial Officer
GOCO · GoHealth, Inc.
Effective
2024-10-14
Filed
October 10, 2024, 7:59 PM ET
appointed Brendan Shanahan as the Company’s Chief Financial Officer, effective October 14, 2024
Departed

Dwight Seegmiller

President and Chief Executive Officer
HBIA · HILLS BANCORPORATION
Effective
2025-01-01
Successor
Lisa Shileny
Filed
October 9, 2024, 7:59 PM ET
Mr. Dwight Seegmiller, President and CEO of the Company and CEO of Hills Bank, will transition to a management advisory role effective January 1, 2025, through his retirement in April of 2025, to assist in the transition of leadership of the Company.
Departed

Kevin P. Riley

President and Chief Executive Officer
FIBK · FIRST INTERSTATE BANCSYSTEM INC
Effective
2024-11-01
Successor
James A. Reuter
Filed
October 9, 2024, 7:59 PM ET
Kevin P. Riley, who, as the Company previously announced on June 14, 2024, will be departing as President and CEO in connection with his successor taking over those positions
Appointed

James A. Reuter

President and Chief Executive Officer
FIBK · FIRST INTERSTATE BANCSYSTEM INC
Effective
2024-11-01
Filed
October 9, 2024, 7:59 PM ET
appointment of James A. Reuter as the Company’s President and Chief Executive Officer ("CEO"), effective end of day on November 1, 2024
Departed

Don Kim

Chief Financial Officer
URGN · UroGen Pharma Ltd.
Effective
2024-10-08
Successor
Christopher Degnan
Filed
October 9, 2024, 7:59 PM ET
pursuant to which Mr. Kim resigned from his positions as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective October 8, 2024
Appointed

Christopher Degnan

Chief Financial Officer
URGN · UroGen Pharma Ltd.
Effective
2024-10-08
Filed
October 9, 2024, 7:59 PM ET
the Company appointed Christopher Degnan as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective on the Effective Date.
Departed

Don Kalkofen

Chief Financial Officer
ACOG · Alpha Cognition Inc.
Effective
2024-10-01
Filed
October 9, 2024, 7:59 PM ET
The Company previously announced the resignation of Mr. Don Kalkofen as Chief Financial Officer on August 27, 2024, effective October 1, 2024.
Appointed

Michael A. Pedraja

Chief Financial Officer
EIG · Employers Holdings, Inc.
Effective
2025-03-31
Filed
October 9, 2024, 7:59 PM ET
Michael A. Pedraja will be appointed as Executive Vice President, Finance and Chief Financial Officer (Designate) on or about February 3, 2025, and will then serve as Executive Vice President, Finance and Chief Financial Officer starting on or about March 31, 2025
Departed

Michael S. Paquette

Chief Financial Officer
EIG · Employers Holdings, Inc.
Effective
2025-03-31
Successor
Michael A. Pedraja
Filed
October 9, 2024, 7:59 PM ET
succeeding Mr. Michael S. Paquette in such role
Appointed

Cameron Pforr

Chief Financial Officer
MPTI · M-tron Industries, Inc.
Effective
2024-10-03
Filed
October 9, 2024, 7:59 PM ET
On October 9, 2024, M-tron Industries, Inc. ("MtronPTI" or the "Company") announced the appointment of Cameron Pforr to serve as Chief Financial Officer, effective October 3, 2024.
Appointed (interim)

William Resides

Interim Financial Officer
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
October 9, 2024, 7:59 PM ET
William Resides – Chief Executive Officer, Interim Financial Officer
Appointed

William Resides

Chief Executive Officer
BRGX · BIOREGENX, INC.
Effective
2024-03-08
Filed
October 9, 2024, 7:59 PM ET
William Resides – Chief Executive Officer, Interim Financial Officer
Appointed (interim)

Joseph A. Riccelli

Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
IVDN · INNOVATIVE DESIGNS INC
Effective
2024-10-03
Filed
October 9, 2024, 7:59 PM ET
The Board also appointed Joseph A. Riccelli to serve as the registrant’s Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer, effective immediately.
Departed

Joseph Riccelli, Sr.

Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
IVDN · INNOVATIVE DESIGNS INC
Effective
2024-10-03
Successor
Joseph A. Riccelli
Filed
October 9, 2024, 7:59 PM ET
the Board accepted the resignation of Joseph Riccelli, Sr. as the registrant’s Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer, effective immediately.
Appointed

Jatinder Dhaliwal

Chief Executive Officer
Virpax Pharmaceuticals, Inc.
Effective
2024-10-06
Filed
October 9, 2024, 7:59 PM ET
On October 6, 2024, the Board appointed Jatinder Dhaliwal, a member of the Board, to serve as Chief Executive Officer of the Company, effective immediately.
Departed

Gerald Bruce

Chief Executive Officer
Virpax Pharmaceuticals, Inc.
Effective
2024-10-05
Successor
Jatinder Dhaliwal
Filed
October 9, 2024, 7:59 PM ET
On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.
Departed

Vinay Shah

Chief Financial Officer
Virpax Pharmaceuticals, Inc.
Effective
2024-10-05
Filed
October 9, 2024, 7:59 PM ET
On October 5, 2024, Gerald Bruce, as Chief Executive Officer and member of the Board of Directors (the “Board”), and Vinay Shah, as Chief Financial Officer, notified the Company of their resignation from their respective positions, effective immediately.
Departed

R. Lee Phegley, Jr.

Chief Financial Officer
Invesco Commercial Real Estate Finance Trust, Inc.
Successor
Courtney Popelka
Filed
October 9, 2024, 7:59 PM ET
On October 2, 2024, R. Lee Phegley, Jr., Chief Financial Officer of Invesco Commercial Real Estate Finance Trust, Inc. (the "Company") notified the Company of his intention to resign from the Company to pursue other opportunities.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.